FDA Approval Activities for this Drug
Cerebyx (Fosphenytoin Sodium injection) Warner-Lambert NDA 20-450/S4, 20-450/S5 | Fosphenytoin Sodium Injection, Bedford Labs, Tentative Approval | Fosphenytoin Sodium Injection, Hospira, Tentative Approval | Fosphenytoin Sodium Injection, Abraxis Pharma, Tentative Approval | Fosphenytoin Sodium Injection, IV Therapeutics, Tentative Approval | Fosphenytoin Sodium Injection, Baxter Healthcare, Tentative Approval | Fosphenytoin Sodium Injection, Wockhardt Inc., Tentative Approval | Fosphenytoin Sodium Injection, Apotex Corp., Tentative Approval | Fosphenytoin Sodium Injection, Baxter Healthcare, Approval | Fosphenytoin Sodium Injection, PharmaForce Inc., Approval | Fosphenytoin Sodium Injection, Bedford Labs, Approval | Fosphenytoin Sodium Injection, Apotex, Approval | Fosphenytoin Sodium Injection, Hospira Inc., Approval | Fosphenytoin Sodium Injection, Wockhardt, Approval | Fosphenytoin Sodium Injection, Abraxis Pharma, Approval | Fosphenytoin Sodium Injection, Teva Parenteral, Approval | Fosphenytoin Sodium Injection, Akorn-Strides, LLC, Approval | Fosphenytoin Sodium Injection, Sun Pharmaceutical Industries, Inc., Approval